Cargando…
Refractory T-Cell Anergy and Rapidly Fatal Progressive Multifocal Leukoencephalopathy After Prolonged CTLA4 Therapy
Progressive multifocal leukoencephalopathy (PML) is a deadly demyelinating disease due to central nervous system replication of the human polyomavirus JC virus (JCV) in immunosuppressed patients. The only effective therapeutic approach is to restore anti-JCV T-cell responses. In this study, we descr...
Autores principales: | Dekeyser, Manon, de Goër de Herve, Marie-Ghislaine, Hendel-Chavez, Houria, Labeyrie, Céline, Adams, David, Nasser, Ghaïdaa Adebs, Gasnault, Jacques, Durrbach, Antoine, Taoufik, Yassine |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5473436/ https://www.ncbi.nlm.nih.gov/pubmed/28638849 http://dx.doi.org/10.1093/ofid/ofx100 |
Ejemplares similares
-
B Cells and Progressive Multifocal Leukoencephalopathy: Search for the Missing Link
por: Durali, Deniz, et al.
Publicado: (2015) -
Efficacy of Recombinant Human Interleukin 7 in a Patient With Severe Lymphopenia-Related Progressive Multifocal Leukoencephalopathy
por: Gasnault, Jacques, et al.
Publicado: (2014) -
Improved Survival of HIV-1-Infected Patients with Progressive Multifocal Leukoencephalopathy Receiving Early 5-Drug Combination Antiretroviral Therapy
por: Gasnault, Jacques, et al.
Publicado: (2011) -
Editorial: Immune Control of JC Virus Infection and Immune Failure during Progressive Multifocal Leukoencephalopathy
por: Taoufik, Yassine, et al.
Publicado: (2017) -
Germline Genetic Risk Variants for Progressive Multifocal Leukoencephalopathy
por: Eis, Peggy S., et al.
Publicado: (2020)